We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+38.56%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$509M
AUM Growth
+$26M
(+5.4%)
Cap. Flow
-$46M
Cap. Flow
% of AUM
-9.03%
Top 10 Holdings %
Top 10 Hldgs %
10.09%
Holding
388
New
139
Increased
33
Reduced
62
Closed
144
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASRT
Assertio
ASRT
|
+$3.68M |
| 2 |
Red Robin
RRGB
|
+$3.46M |
| 3 |
Intapp
INTA
|
+$3.34M |
| 4 |
O-I Glass
OI
|
+$3.16M |
| 5 |
PDF Solutions
PDFS
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rhythm Pharmaceuticals
RYTM
|
+$4.8M |
| 2 |
Target Hospitality
TH
|
+$4.6M |
| 3 |
PDS Biotechnology
PDSB
|
+$4.36M |
| 4 |
Digi International
DGII
|
+$4.3M |
| 5 |
KLX Energy Services
KLXE
|
+$4.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25% |
| 2 | Technology | 21.39% |
| 3 | Industrials | 20.38% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Energy | 7.47% |
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q1 2023 Portfolio in Review
As of Q1 2023, EAM Investors held 388 positions worth $509M, up 5.4% from $483M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
EAM Investors withdrew a net $46M in Q1 2023, closing 144 positions and reducing 62 holdings. Its most notable exit was Rhythm Pharmaceuticals, an estimated $4.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.
Against the trend, EAM Investors opened a new position in Assertio worth $4.67M.
- EAM Investors's largest Q1 2023 buy was Assertio: 48,872 shares worth $4.67M.
- EAM Investors added most to Harrow in Q1 2023, an estimated $1.31M increase.
- EAM Investors's biggest Q1 2023 reduction was ADMA Biologics, cutting an estimated $2.47M.
- EAM Investors fully exited Rhythm Pharmaceuticals in Q1 2023, selling an estimated $4.8M.
- EAM Investors's ten largest holdings make up 10% of its $509M portfolio in Q1 2023.
- EAM Investors opened 139 new positions and closed 144 in Q1 2023.
- EAM Investors's portfolio value rose 5.4% quarter-over-quarter to $509M.
Based on EAM Investors's 13F filing for Q1 2023, filed 15 May 2023.